CAN508 is a potent, ATP-competitive CDK9/cyclin T1 inhibitor with an IC50 of 0.35 µM. CAN508 exhibits a 38-fold selectivity for CDK9/cyclin T over other CDK/cyclin complexes. Antitumor activity[1][2].
Molecular Weight:
218.22
Purity:
99.59
CAS Number:
[140651-18-9]
Formula:
C9H10N6O
Target:
CDK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted